Reports for CODEINE PHOSPHATE
Ingredient
CODEINE PHOSPHATE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CODEINE | 15MG | TABLET | Resolved | 2020-06-18 | 2020-07-09 | 118250 |
| TEVA-CODEINE | 15MG | TABLET | Resolved | 2022-03-24 | 2022-05-19 | 157253 |
| TEVA-CODEINE | 15MG | TABLET | Resolved | 2022-07-25 | 2022-12-22 | 165444 |
| TEVA-CODEINE | 15MG | TABLET | Resolved | 2023-04-27 | 2023-06-09 | 190701 |
| TEVA-CODEINE | 30MG | TABLET | Resolved | 2020-03-26 | 2020-04-02 | 109589 |
| TEVA-CODEINE | 30MG | TABLET | Resolved | 2020-11-27 | 2020-12-17 | 129039 |
| TEVA-CODEINE | 30MG | TABLET | Resolved | 2021-03-25 | 2021-06-03 | 136295 |
| TEVA-CODEINE | 30MG | TABLET | Resolved | 2021-08-05 | 2021-09-30 | 143728 |
| TEVA-CODEINE | 30MG | TABLET | Resolved | 2021-11-04 | 2022-03-09 | 148838 |
| TEVA-CODEINE | 30MG | TABLET | Resolved | 2022-07-25 | 2022-12-22 | 165436 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACETAMINOPHEN, CAFFEINE & CODEINE | 8MG 15MG 300MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117748 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Discontinued | 2017-10-12 | 2017-10-13 | 25692 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 15MG 8MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117751 |
| ATASOL 15 | 325MG 15MG 30MG | TABLET | Discontinued | 2018-05-04 | 2018-05-04 | 48286 |
| ATASOL 15 | 325MG 15MG 30MG | TABLET | To be discontinued | 2019-10-31 | 2019-10-31 | 97538 |
| ATASOL 30 | 325MG 30MG 30MG | TABLET | Discontinued | 2018-05-04 | 2018-05-04 | 48279 |
| ATASOL 30 | 325MG 30MG 30MG | TABLET | Discontinued | 2018-10-22 | 2019-03-26 | 65205 |
| COACTIFED | 30MG 2MG 10MG | SYRUP | Discontinued | 2018-06-13 | 2018-06-13 | 52332 |
| CODEINE 15 | 15MG | TABLET | Discontinued | 2021-07-01 | 2021-07-02 | 141736 |
| CODEINE PHOSPHATE INJECTION USP | 30MG | LIQUID | Discontinued | 2022-04-20 | 2022-04-20 | 159064 |